To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SLC2A3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
559 supporting clones for gene SLC2A3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC370162   .a 1 to 260 1 to 260   tiling clone,   260/260
(100 %)
1 diff
(99.7 %id)
NM_006931.2   .a 9 to 3946 1 to 3938 exact RefSeq,   3938/3938
(100 %)
0 diff
(100 %id)
DA237962 brain .a 12 to 523 2 to 513   capped   512/512
(100 %)
1 diff
(99.9 %id)
M20681   .a 30 to 3943 1 to 3915 exact     3915/3915
(100 %)
7 diff
(99.9 %id)
DA737310   .a 85 to 903 2 to 816   capped   815/823
(99 %)
8 diff
(99.1 %id)
TI_44167009   .a 102 to 911 138 to 943       806/946
(85 %)
22 diff
(97.7 %id)
TI_45214642   .a 102 to 896 68 to 849       782/852
(91 %)
26 diff
(97.0 %id)
TI_44343180   .a 110 to 780 136 to 812   AAA   677/963
(70 %)
21 diff
(97.9 %id)
BG706093 brain, hypothalamus .a 113 to 896 1 to 780       780/781
(99 %)
13 diff
(98.4 %id)
BU599459 mixed (pool of 40 RNAs) .a 115 to 778 1 to 671       671/762
(88 %)
12 diff
(98.5 %id)
CD522679 pooled .a 116 to 780 1 to 665       665/856
(77 %)
8 diff
(99.1 %id)
BI768655 pooled lung and spleen .a 117 to 941 1 to 824       824/845
(97 %)
12 diff
(98.6 %id)
TI_57181079   .a 117 to 941 73 to 896       824/917
(89 %)
15 diff
(98.4 %id)
AK312386 amygdala .a 118 to 1761 1 to 1644 exact     1644/1644
(100 %)
1 diff
(100.0 %id)
DB501341 hypothalamus .a 118 to 344 1 to 228       228/232
(98 %)
3 diff
(98.8 %id)
CD654342 Embryonic Stem cells .a 118 to 927 1 to 806       806/813
(99 %)
15 diff
(98.2 %id)
DA230549 brain .a 119 to 780 2 to 662   capped   661/661
(100 %)
1 diff
(99.9 %id)
BJ992345 hepatoblastoma .a 119 to 609 1 to 491       491/491
(100 %)
2 diff
(99.6 %id)
DA720501   .a 119 to 685 2 to 568   capped   567/567
(100 %)
3 diff
(99.5 %id)
DA727367   .a 119 to 912 2 to 798   capped   797/806
(98 %)
15 diff
(98.2 %id)
DA727379   .a 119 to 891 2 to 772   capped   771/771
(100 %)
15 diff
(98.1 %id)
DA727578   .a 119 to 772 2 to 659   capped   658/776
(84 %)
7 diff
(99.1 %id)
DA727773   .a 119 to 892 2 to 788   capped   787/823
(95 %)
25 diff
(97.0 %id)
DA727820   .a 119 to 912 2 to 800   capped   799/830
(96 %)
20 diff
(97.6 %id)
DA728048   .a 119 to 915 2 to 795   capped   794/794
(100 %)
12 diff
(98.5 %id)
DA728435   .a 119 to 849 2 to 731   capped   730/730
(100 %)
2 diff
(99.8 %id)
DA729388   .a 119 to 836 2 to 716   capped   715/724
(98 %)
8 diff
(98.9 %id)
DA730319   .a 119 to 822 2 to 705   capped   704/704
(100 %)
1 diff
(99.9 %id)
DA731359   .a 119 to 924 2 to 806   capped   805/805
(100 %)
11 diff
(98.7 %id)
DA736773   .a 119 to 876 2 to 758   capped   757/757
(100 %)
3 diff
(99.7 %id)
DA737035   .a 119 to 977 2 to 863   capped   862/863
(99 %)
9 diff
(99.0 %id)
DA737043   .a 119 to 915 2 to 794   capped   793/802
(98 %)
6 diff
(99.3 %id)
DA737168   .a 119 to 936 2 to 813   capped   812/814
(99 %)
9 diff
(98.9 %id)
DA737224   .a 119 to 936 2 to 819   capped   818/824
(99 %)
6 diff
(99.3 %id)
DA737420   .a 119 to 988 2 to 874   capped   873/876
(99 %)
10 diff
(98.9 %id)
DA737434   .a 119 to 876 2 to 759   capped   758/758
(100 %)
1 diff
(99.9 %id)
DA737478   .a 119 to 836 2 to 719   capped   718/718
(100 %)
3 diff
(99.6 %id)
DA737608   .a 119 to 941 2 to 820   capped   819/825
(99 %)
7 diff
(99.2 %id)
DA737611   .a 119 to 943 2 to 826   capped   825/832
(99 %)
6 diff
(99.3 %id)
DA737721   .a 119 to 937 2 to 815   capped   814/814
(100 %)
8 diff
(99.1 %id)
DA737737   .a 119 to 910 2 to 792   capped   791/791
(100 %)
8 diff
(99.0 %id)
DA737853   .a 119 to 936 2 to 820   capped   819/822
(99 %)
3 diff
(99.7 %id)
DA737950   .a 119 to 780 2 to 662   capped   661/661
(100 %)
1 diff
(99.9 %id)
DA738153   .a 119 to 915 2 to 797   capped   796/796
(100 %)
5 diff
(99.4 %id)
DA738188   .a 119 to 915 2 to 797   capped   796/796
(100 %)
3 diff
(99.7 %id)
DA738414   .a 119 to 915 2 to 797   capped   796/807
(98 %)
5 diff
(99.4 %id)
DA760174   .a 119 to 619 2 to 502   tiling clone, capped   501/501
(100 %)
0 diff
(100 %id)
DA865477 Prostate .a 119 to 640 2 to 523   capped   522/522
(100 %)
2 diff
(99.7 %id)
DA408763 thalamus .a 120 to 786 2 to 668   capped   667/667
(100 %)
1 diff
(99.9 %id)
DA571945 whole embryo, mainly body .a 120 to 904 2 to 783   capped   782/782
(100 %)
9 diff
(98.9 %id)
DA729358   .a 120 to 942 2 to 821   capped   820/820
(100 %)
9 diff
(99.0 %id)
DA731204   .a 120 to 876 2 to 760   capped   759/759
(100 %)
7 diff
(99.1 %id)
DA737181   .a 120 to 929 2 to 808   capped   807/807
(100 %)
6 diff
(99.3 %id)
DA737354   .a 120 to 1027 2 to 902   capped Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 901/918
(98 %)
19 diff
(98.0 %id)
DA737546   .a 120 to 943 2 to 823   capped   822/829
(99 %)
8 diff
(99.1 %id)
DA737777   .a 120 to 943 2 to 828   capped   827/886
(93 %)
10 diff
(98.9 %id)
DA738452   .a 120 to 866 2 to 746   capped   745/748
(99 %)
5 diff
(99.4 %id)
DA832614 placenta .a 120 to 844 2 to 728   capped   727/728
(99 %)
7 diff
(99.1 %id)
DA737042   .a 121 to 981 2 to 861   capped   860/860
(100 %)
9 diff
(99.0 %id)
DA737152   .a 121 to 938 2 to 815   capped   814/814
(100 %)
5 diff
(99.4 %id)
DA737219   .a 121 to 936 2 to 816   capped   815/824
(98 %)
5 diff
(99.4 %id)
DA737423   .a 121 to 882 2 to 763   capped Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 762/800
(95 %)
4 diff
(99.5 %id)
DA737465   .a 121 to 992 2 to 874   capped   873/873
(100 %)
10 diff
(98.9 %id)
DA737675   .a 121 to 924 2 to 805   capped   804/806
(99 %)
5 diff
(99.4 %id)
DA738429   .a 121 to 938 2 to 815   capped   814/818
(99 %)
8 diff
(99.1 %id)
DA809727 brain .a 121 to 780 2 to 660   capped   659/659
(100 %)
1 diff
(99.9 %id)
CN303165 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 122 to 847 1 to 726       726/728
(99 %)
5 diff
(99.4 %id)
DA737275   .a 122 to 926 2 to 805   capped   804/806
(99 %)
3 diff
(99.7 %id)
DA737361   .a 122 to 915 2 to 793   capped   792/803
(98 %)
4 diff
(99.6 %id)
DA829165 placenta .a 122 to 832 2 to 713   capped   710/712
(99 %)
6 diff
(99.2 %id)
AW163231 brain, frontal lobe .a 123 to 752 1 to 630       630/630
(100 %)
5 diff
(99.3 %id)
CD656724 Embryonic Stem cells .a 123 to 882 1 to 761       761/761
(100 %)
10 diff
(98.7 %id)
CD654538 Embryonic Stem cells .a 123 to 911 1 to 785       785/841
(93 %)
13 diff
(98.5 %id)
CD654654 Embryonic Stem cells .a 123 to 920 1 to 792       792/792
(100 %)
14 diff
(98.3 %id)
CD654140 Embryonic Stem cells .a 123 to 885 1 to 763       763/763
(100 %)
9 diff
(98.9 %id)
CD642756 Embryonic Stem cells .a 123 to 891 1 to 767       767/771
(99 %)
12 diff
(98.5 %id)
CD653571 Embryonic Stem cells .a 123 to 918 1 to 787       787/788
(99 %)
20 diff
(97.5 %id)
CD643222 Embryonic Stem cells .a 123 to 858 1 to 737       737/737
(100 %)
6 diff
(99.2 %id)
DA737292   .a 123 to 915 2 to 791   capped   790/801
(98 %)
7 diff
(99.2 %id)
DA737719   .a 125 to 926 2 to 801   capped   800/800
(100 %)
7 diff
(99.2 %id)
CN303264 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 127 to 869 8 to 751       744/751
(99 %)
10 diff
(98.7 %id)
CD654528 Embryonic Stem cells .a 127 to 886 4 to 762       759/762
(99 %)
8 diff
(99.0 %id)
CD654975 Embryonic Stem cells .a 127 to 911 5 to 779       775/796
(97 %)
19 diff
(97.7 %id)
CD644148 Embryonic Stem cells .a 127 to 909 5 to 781       777/783
(99 %)
15 diff
(98.1 %id)
CD654364 Embryonic Stem cells .a 127 to 882 5 to 753       749/801
(93 %)
13 diff
(98.4 %id)
CX763142 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 128 to 927 1 to 792     Submitted on the opposite strand 792/799
(99 %)
11 diff
(98.7 %id)
DR157238 human embryonic stem cells differentiated toan early endodermal cell type .a 128 to 829 1 to 702       702/702
(100 %)
1 diff
(99.9 %id)
CD642585 Embryonic Stem cells .a 129 to 902 1 to 770       770/774
(99 %)
11 diff
(98.6 %id)
CD642670 Embryonic Stem cells .a 129 to 876 1 to 745       745/745
(100 %)
14 diff
(98.2 %id)
CD655862 Embryonic Stem cells .a 129 to 931 1 to 796       796/799
(99 %)
17 diff
(97.9 %id)
CD644552 Embryonic Stem cells .a 129 to 850 37 to 751       715/829
(86 %)
14 diff
(98.4 %id)
CN303159 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 130 to 910 1 to 782       782/782
(100 %)
6 diff
(99.3 %id)
TI_57220276   .a 130 to 942 34 to 843       810/889
(91 %)
26 diff
(97.1 %id)
BG765718 melanotic melanoma, high MDR (cell line), skin .a 132 to 897 1 to 770       770/791
(97 %)
23 diff
(97.1 %id)
BI756430 brain .a 132 to 942 1 to 808       808/854
(94 %)
22 diff
(97.5 %id)
BQ723434 sympathetic trunk .a 132 to 943 28 to 842       815/981
(83 %)
17 diff
(98.3 %id)
CN303082 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 133 to 889 1 to 757       757/757
(100 %)
1 diff
(99.9 %id)
CN303132 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 133 to 856 8 to 731       724/731
(99 %)
6 diff
(99.2 %id)
BX355880 Placenta Cot 25-normalized .a 133 to 994 1 to 862       862/862
(100 %)
5 diff
(99.5 %id)
BC039196 Duodenum, adenocarcinoma .a 134 to 3358 1 to 3225 exact tiling clone, available from MGC, AAA   3225/3271
(98 %)
3 diff
(100.0 %id)
CN303218 embryonic stem cells, cell lines H1, H7, andH9 .a 134 to 893 1 to 761       761/761
(100 %)
3 diff
(99.7 %id)
BI489504 pooled brain, lung, testis .a 134 to 1001 1 to 864       864/865
(99 %)
11 diff
(98.8 %id)
BM549289 melanotic melanoma, skin .a 134 to 1093 1 to 968       968/1063
(91 %)
27 diff
(97.5 %id)
BM927919 hepatocellular carcinoma, cell line, Liver .a 134 to 1161 1 to 1034       1032/1034
(99 %)
17 diff
(98.4 %id)
BQ648423 hepatocellular carcinoma, cell line, Liver .a 134 to 1100 1 to 969       969/972
(99 %)
28 diff
(97.2 %id)
BQ652127 hepatocellular carcinoma, cell line, Liver .a 134 to 927 1 to 799       799/947
(84 %)
13 diff
(98.7 %id)
BQ648042 hepatocellular carcinoma, cell line, Liver .a 134 to 1087 1 to 967       967/968
(99 %)
23 diff
(97.7 %id)
DR159040 human embryonic stem cells differentiated toan early endodermal cell type .a 134 to 918 1 to 785       785/785
(100 %)
1 diff
(99.9 %id)
BU181220 large cell carcinoma, lung .a 135 to 981 1 to 855       855/859
(99 %)
10 diff
(98.9 %id)
BX417977 placenta .a 136 to 780 1 to 645       645/808
(79 %)
3 diff
(99.7 %id)
BX342293   .a 136 to 1008 1 to 873       873/873
(100 %)
2 diff
(99.8 %id)
BX342299   .a 136 to 1017 1 to 881       881/881
(100 %)
8 diff
(99.1 %id)
CN484312 eye .a 136 to 757 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BQ898116 dorsal root ganglia .a 136 to 927 1 to 796       796/886
(89 %)
13 diff
(98.6 %id)
CX751781 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 136 to 904 1 to 766     Submitted on the opposite strand 766/768
(99 %)
5 diff
(99.4 %id)
CX763316 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 136 to 873 1 to 730     Submitted on the opposite strand 730/847
(86 %)
9 diff
(99.0 %id)
CX762110 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 136 to 713 15 to 594     Submitted on the opposite strand 580/834
(69 %)
40 diff
(95.3 %id)
DR156222 human embryonic stem cells differentiated toan early endodermal cell type .a 136 to 878 1 to 743       743/743
(100 %)
0 diff
(100 %id)
CK000651 mixed .a 136 to 850 9 to 720       712/723
(98 %)
10 diff
(98.7 %id)
TI_43961322   .a 136 to 1001 64 to 925       862/926
(93 %)
15 diff
(98.4 %id)
CD623452   .a 137 to 640 521 to 17       505/525
(96 %)
2 diff
(99.7 %id)
CD623454   .a 137 to 635 499 to 1       499/503
(99 %)
1 diff
(99.9 %id)
CN303130 embryonic stem cells, DMSO-treated H9 cellline .a 137 to 486 1 to 350       350/350
(100 %)
0 diff
(100 %id)
CD656122 Embryonic Stem cells .a 137 to 882 12 to 752       741/773
(95 %)
13 diff
(98.4 %id)
CN303234 embryonic stem cells, DMSO-treated H9 cellline .a 138 to 898 1 to 763       763/763
(100 %)
3 diff
(99.7 %id)
ES309307 occipital hair of pubic hypotrichosispatient, skin .a 138 to 656 35 to 541       507/765
(66 %)
19 diff
(97.6 %id)
CD657291 Embryonic Stem cells .a 138 to 927 12 to 797       786/817
(96 %)
14 diff
(98.3 %id)
AA381487   .a 139 to 450 1 to 312       312/312
(100 %)
0 diff
(100 %id)
CN303157 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 139 to 892 9 to 762       754/762
(98 %)
6 diff
(99.3 %id)
CN303240 embryonic stem cells, cell lines H1, H7, andH9 .a 139 to 865 1 to 727       727/727
(100 %)
0 diff
(100 %id)
CN303243 embryonic stem cells, cell lines H1, H7, andH9 .a 139 to 752 1 to 614       614/614
(100 %)
0 diff
(100 %id)
BX335132 Placenta Cot 25-normalized .a 139 to 1089 1 to 945       945/945
(100 %)
15 diff
(98.5 %id)
CD672991 eye, Iris .a 139 to 811 1 to 673       673/673
(100 %)
0 diff
(100 %id)
BM480105 duodenal adenocarcinoma, cell line, small intestine .a 139 to 937 1 to 811       811/1079
(75 %)
36 diff
(96.7 %id)
CN303176 embryonic stem cells, cell lines H1, H7, andH9 .a 140 to 836 1 to 698       698/698
(100 %)
1 diff
(99.9 %id)
CN303228 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 140 to 859 1 to 720       720/720
(100 %)
1 diff
(99.9 %id)
AA218573 brain, neuroepithelial cells .a 140 to 584 1 to 451       451/452
(99 %)
7 diff
(98.5 %id)
CX787021 human embryonic stem cells .a 140 to 860 1 to 721       721/721
(100 %)
0 diff
(100 %id)
TI_57216157   .a 140 to 931 70 to 871       802/1084
(73 %)
28 diff
(97.5 %id)
CA405841 adipose .a 141 to 755 1 to 615       615/615
(100 %)
0 diff
(100 %id)
CN303105 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 749 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CN303109 embryonic stem cells, cell lines H1, H7, andH9 .a 141 to 750 1 to 610       610/610
(100 %)
0 diff
(100 %id)
CN303161 embryonic stem cells, cell lines H1, H7, andH9 .a 141 to 865 1 to 725       725/725
(100 %)
2 diff
(99.8 %id)
CN303184 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 812 1 to 673       673/673
(100 %)
1 diff
(99.9 %id)
CN303190 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 595 1 to 455       455/455
(100 %)
0 diff
(100 %id)
CN303208 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 835 1 to 695       695/695
(100 %)
0 diff
(100 %id)
CN303214 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 753 1 to 613       613/613
(100 %)
0 diff
(100 %id)
CN303221 embryonic stem cells, cell lines H1, H7, andH9 .a 141 to 607 1 to 467       467/467
(100 %)
0 diff
(100 %id)
CN303266 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 605 1 to 465       465/465
(100 %)
0 diff
(100 %id)
CN303278 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 141 to 415 1 to 275       275/275
(100 %)
0 diff
(100 %id)
BI755018 brain .a 141 to 931 1 to 801       801/1014
(78 %)
23 diff
(97.8 %id)
BU849981 ovary, teratocarcinoma, cell line .a 141 to 1059 1 to 923       923/924
(99 %)
18 diff
(98.1 %id)
CV806806 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 141 to 932 1 to 798       796/882
(90 %)
17 diff
(98.1 %id)
CN303121 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 142 to 922 1 to 781       781/781
(100 %)
2 diff
(99.8 %id)
DR158716 human embryonic stem cells differentiated toan early endodermal cell type .a 142 to 871 1 to 730       730/730
(100 %)
0 diff
(100 %id)
AA171601   .a 143 to 578 1 to 436       436/436
(100 %)
0 diff
(100 %id)
CN303155 embryonic stem cells, DMSO-treated H9 cellline .a 146 to 734 1 to 589       589/589
(100 %)
0 diff
(100 %id)
CN303123 embryonic stem cells, cell lines H1, H7, andH9 .a 148 to 718 1 to 571       571/571
(100 %)
0 diff
(100 %id)
CN303144 embryonic stem cells, cell lines H1, H7, andH9 .a 148 to 864 1 to 717       717/717
(100 %)
2 diff
(99.8 %id)
CN303229 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 148 to 873 1 to 727       727/727
(100 %)
1 diff
(99.9 %id)
CN303210 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 162 to 833 1 to 672       672/672
(100 %)
1 diff
(99.9 %id)
CD653560 Embryonic Stem cells .a 162 to 927 4 to 765       762/835
(91 %)
13 diff
(98.5 %id)
TI_154157212   .a 162 to 658 77 to 579       503/503
(100 %)
24 diff
(95.3 %id)
BU429169 lymph .a 163 to 540 1 to 378     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 378/378
(100 %)
6 diff
(98.5 %id)
BQ068321 brain .a 167 to 1014 16 to 865       850/990
(85 %)
22 diff
(97.8 %id)
CN303172 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 168 to 865 1 to 698       698/698
(100 %)
0 diff
(100 %id)
CN303087 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 169 to 737 1 to 569       569/569
(100 %)
0 diff
(100 %id)
TI_154150096   .a 170 to 694 78 to 610       533/807
(66 %)
20 diff
(97.6 %id)
CN303128 embryonic stem cells, DMSO-treated H9 cellline .a 171 to 724 1 to 554       554/554
(100 %)
0 diff
(100 %id)
CD623456   .a 178 to 640 479 to 17       463/479
(96 %)
0 diff
(100 %id)
BI021109 marrow .a 182 to 531 350 to 1       350/350
(100 %)
0 diff
(100 %id)
DA191014 amygdala .a 189 to 757 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA211874 brain .a 189 to 750 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
AA205794   .a 194 to 732 1 to 533     Submitted on the opposite strand 533/533
(100 %)
8 diff
(98.5 %id)
AW408655 lymph .a 210 to 594 1 to 385     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 385/385
(100 %)
4 diff
(99.0 %id)
CN303263 embryonic stem cells, DMSO-treated H9 cellline .a 215 to 943 1 to 732       732/738
(99 %)
9 diff
(98.8 %id)
TI_154148529   .a 217 to 777 91 to 654       564/582
(96 %)
23 diff
(96.1 %id)
CN303181 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 219 to 925 1 to 707       707/707
(100 %)
0 diff
(100 %id)
CN303129 embryonic stem cells, cell lines H1, H7, andH9 .a 230 to 484 1 to 255       255/255
(100 %)
0 diff
(100 %id)
DA239745 brain .a 250 to 812 2 to 564   capped   563/563
(100 %)
0 diff
(100 %id)
DA336244 hippocampus .a 256 to 635 2 to 381   capped   380/380
(100 %)
0 diff
(100 %id)
BF980717 duodenal adenocarcinoma, cell line, small intestine .a 267 to 1010 1 to 742       742/973
(76 %)
33 diff
(96.7 %id)
CR457413   .a 271 to 1761 1 to 1491 exact     1491/1491
(100 %)
1 diff
(100.0 %id)
CV025026 mixed .a 271 to 879 1 to 609       609/609
(100 %)
0 diff
(100 %id)
CX759244 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 271 to 943 1 to 671     Submitted on the opposite strand 671/691
(97 %)
11 diff
(98.5 %id)
CD644645 Embryonic Stem cells .a 271 to 1020 8 to 757       750/757
(99 %)
11 diff
(98.6 %id)
TI_1948133593   .a 271 to 701 127 to 558       432/1289
(33 %)
7 diff
(99.5 %id)
TI_1948133594   .a 271 to 1235 129 to 1092       964/1343
(71 %)
25 diff
(98.2 %id)
TI_1948133595   .a 271 to 1129 126 to 990       865/1355
(63 %)
29 diff
(97.9 %id)
TI_1948134129   .a 271 to 920 128 to 782       655/1323
(49 %)
19 diff
(98.6 %id)
TI_1948134130   .a 271 to 1221 133 to 1083       951/1381
(68 %)
19 diff
(98.7 %id)
TI_1948134131   .a 271 to 1093 127 to 961       835/1398
(59 %)
21 diff
(98.5 %id)
TI_1948134674   .a 271 to 677 126 to 532       407/1287
(31 %)
5 diff
(99.7 %id)
TI_1948134675   .a 271 to 1132 129 to 991       863/1359
(63 %)
6 diff
(99.6 %id)
TI_1948134676   .a 271 to 1103 125 to 961       835/1339
(62 %)
38 diff
(97.2 %id)
TI_1948135209   .a 271 to 869 125 to 720       596/1327
(44 %)
28 diff
(97.9 %id)
TI_1948135210   .a 271 to 1339 129 to 1186       924/1364
(67 %)
25 diff
(98.2 %id)
TI_1948135211   .a 271 to 1127 127 to 986       859/1349
(63 %)
49 diff
(96.4 %id)
BG115915 duodenal adenocarcinoma, cell line, small intestine .a 301 to 981 1 to 680       680/891
(76 %)
10 diff
(98.9 %id)
CN303209 embryonic stem cells, DMSO-treated H9 cellline .a 320 to 954 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BM802877 duodenal adenocarcinoma, cell line, small intestine .a 362 to 1319 1 to 965       965/1018
(94 %)
17 diff
(98.4 %id)
BG116681 duodenal adenocarcinoma, cell line, small intestine .a 369 to 1087 1 to 718       718/859
(83 %)
18 diff
(98.0 %id)
BM907815 large cell carcinoma, lung .a 389 to 1205 1 to 821       821/1023
(80 %)
8 diff
(99.3 %id)
CN303097 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 401 to 925 1 to 525       525/525
(100 %)
0 diff
(100 %id)
CN303094 embryonic stem cells, cell lines H1, H7, andH9 .a 415 to 1092 1 to 676       676/676
(100 %)
5 diff
(99.3 %id)
BF876345 lung_tumor .a 418 to 551 136 to 7     Submitted on the opposite strand 130/136
(95 %)
0 diff
(100 %id)
CN303099 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 430 to 1131 1 to 702       702/702
(100 %)
0 diff
(100 %id)
DA863478 placenta .a 443 to 1109 2 to 668   capped   667/667
(100 %)
0 diff
(100 %id)
CN303257 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 496 to 920 1 to 425       425/425
(100 %)
0 diff
(100 %id)
DA738332   .a 507 to 1321 2 to 818   capped   817/818
(99 %)
5 diff
(99.4 %id)
CD656442 Embryonic Stem cells .a 524 to 1233 46 to 753       708/852
(83 %)
7 diff
(99.2 %id)
CD623450   .a 534 to 1168 627 to 1       627/721
(86 %)
9 diff
(98.8 %id)
BM561608 duodenal adenocarcinoma, cell line, small intestine .a 537 to 1533 1 to 1011       1011/1015
(99 %)
26 diff
(97.5 %id)
BQ333644 marrow .a 559 to 943 407 to 19       389/408
(95 %)
2 diff
(99.6 %id)
CN303137 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 564 to 1016 1 to 453       453/453
(100 %)
0 diff
(100 %id)
BQ333648 marrow .a 612 to 943 351 to 20       332/351
(94 %)
1 diff
(99.8 %id)
CN303259 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 612 to 1293 1 to 682       682/682
(100 %)
4 diff
(99.5 %id)
CD704579 normal nasopharynx .a 636 to 1300 23 to 687       665/687
(96 %)
6 diff
(99.2 %id)
CN303170 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 641 to 1322 36 to 717       682/717
(95 %)
6 diff
(99.2 %id)
TI_1948134133   .a 679 to 1760 1199 to 127       1073/1333
(80 %)
37 diff
(97.3 %id)
CD643983 Embryonic Stem cells .a 690 to 1461 12 to 780       769/782
(98 %)
13 diff
(98.4 %id)
TI_1948135213   .a 760 to 1760 1128 to 128       1001/1335
(74 %)
30 diff
(97.8 %id)
TI_1948134677   .a 765 to 1760 1130 to 126       1005/1309
(76 %)
31 diff
(97.7 %id)
TI_1948133597   .a 771 to 1760 1112 to 128       985/1289
(76 %)
24 diff
(98.2 %id)
TI_1948133598   .a 772 to 1760 1114 to 126       989/1170
(84 %)
18 diff
(98.5 %id)
BG114913 duodenal adenocarcinoma, cell line, small intestine .a 778 to 1493 1 to 704       704/911
(77 %)
22 diff
(97.6 %id)
TI_1948134134   .a 778 to 1760 1105 to 128       978/1161
(84 %)
19 diff
(98.4 %id)
CN303269 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 780 to 1441 1 to 662       662/662
(100 %)
0 diff
(100 %id)
CV380466 ovary .a 780 to 1168 388 to 1     Submitted on the opposite strand 388/388
(100 %)
9 diff
(97.7 %id)
TI_1948134678   .a 781 to 1760 1104 to 129       976/1252
(77 %)
22 diff
(98.3 %id)
TI_1948133596   .a 782 to 1760 1107 to 125       983/1298
(75 %)
27 diff
(98.0 %id)
TI_1948134132   .a 784 to 1760 1103 to 126       978/1276
(76 %)
22 diff
(98.3 %id)
TI_1948134679   .a 784 to 1760 1103 to 129       975/1166
(83 %)
21 diff
(98.2 %id)
TI_1948135212   .a 784 to 1760 1097 to 125       973/1253
(77 %)
24 diff
(98.1 %id)
CD642708 Embryonic Stem cells .a 789 to 1566 9 to 783       775/783
(98 %)
8 diff
(99.0 %id)
CN303239 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 795 to 1196 1 to 402       402/402
(100 %)
0 diff
(100 %id)
DA715046   .a 798 to 1304 2 to 508   capped   507/507
(100 %)
0 diff
(100 %id)
CN303219 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 813 to 1614 1 to 801       801/801
(100 %)
1 diff
(99.9 %id)
BM553863 duodenal adenocarcinoma, cell line, small intestine .a 822 to 1733 1 to 926       926/1051
(88 %)
20 diff
(98.1 %id)
BI756042 brain .a 832 to 1668 1 to 841       841/841
(100 %)
20 diff
(97.7 %id)
TI_57221255   .a 832 to 1668 74 to 914       841/914
(92 %)
24 diff
(97.4 %id)
DA738403   .a 832 to 1702 2 to 871   capped   870/871
(99 %)
4 diff
(99.6 %id)
CN303262 embryonic stem cells, cell lines H1, H7, andH9 .a 847 to 1596 1 to 750       750/750
(100 %)
0 diff
(100 %id)
BM562829 duodenal adenocarcinoma, cell line, small intestine .a 887 to 1798 1 to 917       917/1005
(91 %)
18 diff
(98.3 %id)
BQ930037 leiomyosarcoma, uterus .a 897 to 1820 12 to 935       924/935
(98 %)
19 diff
(98.0 %id)
BQ718235 sympathetic trunk .a 902 to 1670 1 to 773       773/908
(85 %)
14 diff
(98.5 %id)
BM807032 duodenal adenocarcinoma, cell line, small intestine .a 908 to 1859 1 to 961       961/1030
(93 %)
22 diff
(97.9 %id)
DA443348 tongue, tumor tissue .a 911 to 1475 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
BM561800 duodenal adenocarcinoma, cell line, small intestine .a 919 to 1915 1 to 1004       1004/1005
(99 %)
23 diff
(97.8 %id)
BU175321 large cell carcinoma, lung .a 933 to 1783 1 to 862       862/867
(99 %)
25 diff
(97.2 %id)
TI_1948135214   .a 944 to 1760 944 to 128       817/1177
(69 %)
2 diff
(99.9 %id)
AA100406 brain, neuroepithelial cells .a 946 to 1368 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
DA731332   .a 968 to 1727 2 to 760   capped   759/759
(100 %)
2 diff
(99.8 %id)
CN303110 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 988 to 1644 1 to 657       657/657
(100 %)
0 diff
(100 %id)
DA731793   .a 995 to 1718 2 to 726   capped   725/725
(100 %)
7 diff
(99.1 %id)
BQ333326 pnet .a 1037 to 1540 1 to 512       512/519
(98 %)
36 diff
(93.1 %id)
CN303233 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1047 to 1683 1 to 637       637/637
(100 %)
0 diff
(100 %id)
BU850207 ovary, teratocarcinoma, cell line .a 1048 to 1886 1 to 851       851/922
(92 %)
17 diff
(98.2 %id)
DA667062   .a 1053 to 1608 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CN303093 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1058 to 1383 1 to 326       326/326
(100 %)
0 diff
(100 %id)
CN303271 embryonic stem cells, cell lines H1, H7, andH9 .a 1071 to 1566 1 to 496       496/496
(100 %)
0 diff
(100 %id)
DB145629 thymus .a 1082 to 1628 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN303088 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1132 to 1895 13 to 776       763/776
(98 %)
9 diff
(98.9 %id)
DA741067   .a 1136 to 1295 2 to 161   capped   160/160
(100 %)
0 diff
(100 %id)
BF089373 head_neck .a 1139 to 1301 168 to 3       166/168
(98 %)
4 diff
(97.7 %id)
DR156664 human embryonic stem cells differentiated toan early endodermal cell type .a 1148 to 1842 1 to 695       695/695
(100 %)
0 diff
(100 %id)
CD656574 Embryonic Stem cells .a 1150 to 1924 12 to 768       757/793
(95 %)
27 diff
(96.6 %id)
BM556019 duodenal adenocarcinoma, cell line, small intestine .a 1151 to 2122 1 to 980       980/999
(98 %)
22 diff
(97.8 %id)
CN303236 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1158 to 1667 1 to 510       510/510
(100 %)
0 diff
(100 %id)
DA817664   .a 1167 to 1743 2 to 578   capped   577/577
(100 %)
0 diff
(100 %id)
BF340060 brain, glioblastoma with EGFR amplification .a 1169 to 1948 1 to 782       782/864
(90 %)
25 diff
(97.2 %id)
AY034634 articular cartilage .a 1172 to 1628 1 to 457       457/457
(100 %)
0 diff
(100 %id)
BM476335 duodenal adenocarcinoma, cell line, small intestine .a 1205 to 2243 1 to 1060       1060/1098
(96 %)
24 diff
(97.9 %id)
CN303246 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1207 to 1712 1 to 506       506/506
(100 %)
0 diff
(100 %id)
CX781806 human embryonic stem cells .a 1211 to 2088 1 to 878     Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 878/878
(100 %)
1 diff
(99.9 %id)
CB267921 adipose .a 1212 to 1673 1 to 462       462/462
(100 %)
0 diff
(100 %id)
DA737863   .a 1231 to 2089 2 to 861   capped   860/860
(100 %)
8 diff
(99.1 %id)
BM558108 duodenal adenocarcinoma, cell line, small intestine .a 1237 to 2021 1 to 787       787/1024
(76 %)
13 diff
(98.8 %id)
CD644254 Embryonic Stem cells .a 1245 to 2012 1 to 768       768/841
(91 %)
14 diff
(98.4 %id)
CN303226 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1251 to 1993 1 to 743       743/743
(100 %)
5 diff
(99.4 %id)
CN303095 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1254 to 2023 1 to 771       771/771
(100 %)
1 diff
(99.9 %id)
DB500492 hypothalamus .a 1257 to 1735 1 to 479       479/479
(100 %)
0 diff
(100 %id)
DB505803 hypothalamus .a 1257 to 1762 1 to 506       506/506
(100 %)
0 diff
(100 %id)
DA737519   .a 1286 to 2083 2 to 796   capped   795/795
(100 %)
6 diff
(99.3 %id)
CN303104 embryonic stem cells, DMSO-treated H9 cellline .a 1308 to 1571 1 to 264       264/264
(100 %)
0 diff
(100 %id)
DA914554   .a 1328 to 1882 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BM556081 duodenal adenocarcinoma, cell line, small intestine .a 1344 to 2314 1 to 983       983/1041
(94 %)
23 diff
(97.8 %id)
DA419127 cord Blood .a 1345 to 1890 2 to 547   capped   546/546
(100 %)
0 diff
(100 %id)
CN303211 embryonic stem cells, DMSO-treated H9 cellline .a 1346 to 1968 1 to 623       623/623
(100 %)
0 diff
(100 %id)
BU595579 mixed (pool of 40 RNAs) .a 1351 to 2115 1 to 768       768/773
(99 %)
10 diff
(98.8 %id)
BM562542 duodenal adenocarcinoma, cell line, small intestine .a 1355 to 2243 1 to 898       898/1035
(86 %)
15 diff
(98.6 %id)
CV813166 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1359 to 2101 1 to 749       749/893
(83 %)
27 diff
(97.0 %id)
AK074861   .a 1368 to 3938 1 to 2568   tiling clone, available from FLJ,   2568/2568
(100 %)
3 diff
(99.9 %id)
BF983849 duodenal adenocarcinoma, cell line, small intestine .a 1382 to 2197 3 to 812       810/874
(92 %)
34 diff
(96.2 %id)
BQ441087 leiomyosarcoma, uterus .a 1393 to 2264 1 to 888       888/888
(100 %)
29 diff
(96.8 %id)
CN303106 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1394 to 1717 1 to 324       324/324
(100 %)
0 diff
(100 %id)
ES309713 occipital hair of pubic hypotrichosispatient, skin .a 1428 to 2095 34 to 692       659/767
(85 %)
15 diff
(98.1 %id)
DA956096 Spleen .a 1433 to 1988 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BY997044   .a 1468 to 2080 30 to 642       613/642
(95 %)
7 diff
(99.0 %id)
BG506763 lung .a 1482 to 2260 1 to 775       775/775
(100 %)
16 diff
(98.0 %id)
CN303251 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1515 to 2308 1 to 792       792/792
(100 %)
6 diff
(99.3 %id)
CD520503 pooled .a 1556 to 2285 1 to 733       733/745
(98 %)
13 diff
(98.3 %id)
DA379423 thalamus .a 1560 to 2099 2 to 541   capped   540/540
(100 %)
0 diff
(100 %id)
DA729685   .a 1565 to 2097 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA737764   .a 1587 to 2284 2 to 699   capped   698/700
(99 %)
3 diff
(99.6 %id)
DA937425 Spleen .a 1596 to 2166 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BU838556 dorsal root ganglia .a 1601 to 2513 26 to 942       917/943
(97 %)
14 diff
(98.6 %id)
DA818728   .a 1609 to 2163 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
BM475101 duodenal adenocarcinoma, cell line, small intestine .a 1619 to 2523 1 to 910       910/927
(98 %)
12 diff
(98.8 %id)
AL702725 human skeletal muscle .a 1631 to 1968 1 to 338       338/338
(100 %)
0 diff
(100 %id)
BM926950 brain .a 1638 to 2519 1 to 886       886/1028
(86 %)
19 diff
(98.2 %id)
CX783311 human embryonic stem cells .a 1644 to 2451 1 to 806     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 806/806
(100 %)
2 diff
(99.8 %id)
BX342298   .a 1647 to 2569 951 to 34       918/951
(96 %)
0 diff
(100 %id)
DA563345 heart .a 1649 to 2186 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
BX334644 Placenta Cot 25-normalized .a 1651 to 2593 941 to 1       941/941
(100 %)
2 diff
(99.8 %id)
CX753812 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1655 to 2424 1 to 765     Submitted on the opposite strand 765/769
(99 %)
9 diff
(98.9 %id)
DB198725 trachea .a 1655 to 2241 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
BX342292   .a 1662 to 2597 946 to 13       934/946
(98 %)
0 diff
(100 %id)
BQ371743 prostate_normal .a 1695 to 2213 532 to 14       519/548
(94 %)
0 diff
(100 %id)
AF114119 lung .a 1696 to 1926 231 to 1       231/236
(97 %)
1 diff
(99.6 %id)
BX412534 placenta .a 1731 to 2625 900 to 4       897/900
(99 %)
0 diff
(100 %id)
CN303275 embryonic stem cells, DMSO-treated H9 cellline .a 1733 to 2354 1 to 622       622/622
(100 %)
0 diff
(100 %id)
BE696573 colon .a 1734 to 1915 196 to 15       182/196
(92 %)
0 diff
(100 %id)
CN303272 embryonic stem cells, DMSO-treated H9 cellline .a 1742 to 2179 1 to 438       438/438
(100 %)
0 diff
(100 %id)
BQ722103 sympathetic trunk .a 1764 to 2673 1 to 912       912/912
(100 %)
9 diff
(99.1 %id)
BQ721115 sympathetic trunk .a 1764 to 2676 1 to 915       915/916
(99 %)
12 diff
(98.7 %id)
BF848098 lung_normal .a 1784 to 2073 297 to 9     Submitted on the opposite strand 289/364
(79 %)
0 diff
(100 %id)
BI019994 marrow .a 1784 to 2207 424 to 1       424/424
(100 %)
2 diff
(99.6 %id)
DR156042 human embryonic stem cells differentiated toan early endodermal cell type .a 1821 to 2635 1 to 814       814/814
(100 %)
1 diff
(99.9 %id)
BM543363 duodenal adenocarcinoma, cell line, small intestine .a 1825 to 2705 1 to 893       893/989
(90 %)
66 diff
(93.4 %id)
CX785692 human embryonic stem cells .a 1827 to 2644 1 to 817       817/817
(100 %)
1 diff
(99.9 %id)
R58436   .a 1870 to 2211 1 to 337       337/343
(98 %)
16 diff
(95.4 %id)
AL041909 testis .a 1884 to 2205 1 to 322       322/384
(83 %)
3 diff
(99.3 %id)
BE018415 cervix .a 1886 to 2390 1 to 504       504/504
(100 %)
4 diff
(99.3 %id)
EH336864   .a 1894 to 1943 1 to 50       50/50
(100 %)
0 diff
(100 %id)
CX165085 human embryonic stem cells differentiated toan early endodermal cell type .a 1905 to 2742 1 to 836       836/836
(100 %)
2 diff
(99.8 %id)
EL947779 eyeball .a 1935 to 2512 1 to 578       578/578
(100 %)
4 diff
(99.4 %id)
DR980007.
matches multiple genes
placenta .a 1936 to 2029 93 to 1     also hits gene SLC2A14 93/98
(94 %)
3 diff
(97.0 %id)
DR977775.
matches multiple genes
brain .a 1954 to 2025 73 to 3     also hits gene SLC2A14 71/82
(86 %)
0 diff
(100 %id)
R36839   .a 1955 to 2108 1 to 153       153/153
(100 %)
1 diff
(99.4 %id)
AA406551 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1988 to 2329 1 to 334   fully sequenced,   334/334
(100 %)
3 diff
(99.2 %id)
DB370035   .a 2001 to 2624 616 to 1       616/618
(99 %)
16 diff
(97.5 %id)
TI_154133323   .a 2004 to 2630 727 to 95   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 633/1003
(63 %)
15 diff
(98.6 %id)
DB370333   .a 2056 to 2625 568 to 1       568/568
(100 %)
2 diff
(99.7 %id)
DB363509   .a 2058 to 2625 566 to 1       566/566
(100 %)
4 diff
(99.3 %id)
DB369893   .a 2062 to 2630 564 to 1       564/566
(99 %)
10 diff
(98.3 %id)
DB363303   .a 2066 to 2625 559 to 1       559/562
(99 %)
11 diff
(98.1 %id)
DB370217   .a 2075 to 2630 553 to 1       553/556
(99 %)
4 diff
(99.3 %id)
DB369331   .a 2076 to 2630 555 to 1       555/555
(100 %)
7 diff
(98.8 %id)
DB369944   .a 2076 to 2625 560 to 13   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 548/557
(98 %)
5 diff
(99.2 %id)
DB358882 whole embryo, mainly body .a 2087 to 2630 544 to 1       544/544
(100 %)
3 diff
(99.5 %id)
AA205793   .a 2092 to 2625 540 to 3     Submitted on the opposite strand 538/544
(98 %)
0 diff
(100 %id)
DB370073   .a 2106 to 2630 522 to 1       522/522
(100 %)
3 diff
(99.5 %id)
BY996380   .a 2114 to 2748 18 to 651       634/651
(97 %)
6 diff
(99.1 %id)
AW575749 lymph .a 2142 to 2630 505 to 18   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 488/488
(100 %)
1 diff
(99.8 %id)
DB370018   .a 2143 to 2629 485 to 1       485/489
(99 %)
2 diff
(99.6 %id)
DB572217 hypothalamus .a 2146 to 2630 1 to 485     Submitted on the opposite strand 485/485
(100 %)
1 diff
(99.8 %id)
DB329452 Prostate .a 2148 to 2625 477 to 1       477/477
(100 %)
1 diff
(99.8 %id)
DB570683 hypothalamus .a 2151 to 2630 1 to 481     Submitted on the opposite strand 481/481
(100 %)
3 diff
(99.4 %id)
DB573417 hypothalamus .a 2162 to 2629 1 to 468     Submitted on the opposite strand 468/468
(100 %)
3 diff
(99.4 %id)
DB370352   .a 2165 to 2627 468 to 4       465/468
(99 %)
0 diff
(100 %id)
DB370754   .a 2174 to 2630 456 to 1       456/456
(100 %)
4 diff
(99.2 %id)
DB535996 hippocampus .a 2179 to 2625 1 to 449     Submitted on the opposite strand 449/449
(100 %)
11 diff
(97.6 %id)
AW157226 brain, frontal lobe .a 2202 to 2871 669 to 1       669/669
(100 %)
16 diff
(97.7 %id)
BQ941264 sciatic nerve .a 2204 to 3030 1 to 845       845/909
(92 %)
21 diff
(97.7 %id)
BP393484 pancreatic islet .a 2206 to 2625 1 to 420     Submitted on the opposite strand 420/420
(100 %)
0 diff
(100 %id)
DB369725   .a 2206 to 2630 425 to 1       425/426
(99 %)
0 diff
(100 %id)
DB373879 placenta .a 2206 to 2630 425 to 1       425/427
(99 %)
3 diff
(99.3 %id)
DB559743 hypothalamus .a 2233 to 2630 1 to 398     Submitted on the opposite strand 398/398
(100 %)
7 diff
(98.3 %id)
CN303207 embryonic stem cells, cell lines H1, H7, andH9 .a 2234 to 2853 1 to 620       620/620
(100 %)
1 diff
(99.9 %id)
BY996173   .a 2247 to 2871 16 to 639       624/639
(97 %)
6 diff
(99.1 %id)
AA171500   .a 2275 to 2625 355 to 3       353/356
(99 %)
0 diff
(100 %id)
AU185976 skin .a 2276 to 2617 1 to 342       342/342
(100 %)
0 diff
(100 %id)
DA590964 lung .a 2276 to 2842 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
CX781755 human embryonic stem cells .a 2281 to 2630 388 to 39   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 350/350
(100 %)
5 diff
(98.6 %id)
AA350577 brain .a 2285 to 2630 346 to 1       346/346
(100 %)
0 diff
(100 %id)
CN303255 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2294 to 2785 1 to 492       492/492
(100 %)
0 diff
(100 %id)
AA406552 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2299 to 2625 323 to 1   fully sequenced,   323/323
(100 %)
0 diff
(100 %id)
BE774315 uterus .a 2304 to 2509 225 to 18       208/225
(92 %)
0 diff
(100 %id)
DA727435   .a 2309 to 3051 2 to 750   capped   749/756
(99 %)
22 diff
(97.1 %id)
BM706092 eye, lens .a 2315 to 2890 1 to 576       576/576
(100 %)
0 diff
(100 %id)
CX757099 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2345 to 3115 1 to 764     Submitted on the opposite strand 764/764
(100 %)
8 diff
(99.0 %id)
CN303227 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2398 to 3055 1 to 659       659/659
(100 %)
1 diff
(99.9 %id)
CN303215 embryonic stem cells, DMSO-treated H9 cellline .a 2421 to 3024 1 to 604       604/604
(100 %)
0 diff
(100 %id)
R54139 whole brain .a 2437 to 2829 1 to 406       406/410
(99 %)
16 diff
(96.1 %id)
CN303136 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2438 to 3110 1 to 674       674/674
(100 %)
2 diff
(99.8 %id)
CX784309 human embryonic stem cells .a 2454 to 2970 1 to 517       517/517
(100 %)
0 diff
(100 %id)
CN303194 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2476 to 3142 1 to 667       667/667
(100 %)
0 diff
(100 %id)
CN303158 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2480 to 3177 1 to 698       698/698
(100 %)
0 diff
(100 %id)
CN303122 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2518 to 3183 1 to 666       666/666
(100 %)
0 diff
(100 %id)
CN303084 embryonic stem cells, DMSO-treated H9 cellline .a 2534 to 3286 9 to 761       753/761
(98 %)
6 diff
(99.3 %id)
CN303127 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2563 to 3166 1 to 604       604/604
(100 %)
0 diff
(100 %id)
BU164029 large cell carcinoma, lung .a 2588 to 3479 1 to 901       901/902
(99 %)
17 diff
(98.2 %id)
CX751580 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2593 to 3352 1 to 753     Submitted on the opposite strand 753/756
(99 %)
11 diff
(98.6 %id)
BF983624 duodenal adenocarcinoma, cell line, small intestine .a 2633 to 3409 1 to 770       770/781
(98 %)
19 diff
(97.6 %id)
BY995271   .a 2640 to 3327 10 to 697       688/697
(98 %)
6 diff
(99.2 %id)
BI754722 brain .a 2654 to 3539 1 to 892       892/918
(97 %)
38 diff
(95.9 %id)
TI_57217423   .a 2654 to 3539 101 to 992       892/1018
(87 %)
38 diff
(96.3 %id)
BP343186 stomach mucosa .a 2671 to 3255 1 to 585       585/585
(100 %)
0 diff
(100 %id)
CN303180 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 2697 to 3162 1 to 466       466/466
(100 %)
0 diff
(100 %id)
DB577096 hypothalamus .a 2699 to 3188 1 to 490     Submitted on the opposite strand 490/491
(99 %)
1 diff
(99.8 %id)
DA728263   .a 2704 to 3450 2 to 756   capped   755/803
(94 %)
14 diff
(98.3 %id)
DA728244   .a 2706 to 3450 2 to 752   capped   751/829
(90 %)
10 diff
(98.8 %id)
DB571649 hypothalamus .a 2710 to 3188 1 to 479     Submitted on the opposite strand 479/480
(99 %)
1 diff
(99.8 %id)
BQ652618 hepatocellular carcinoma, cell line, Liver .a 2722 to 3613 1 to 906       906/911
(99 %)
36 diff
(96.1 %id)
CN303254 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2723 to 3506 1 to 784       784/784
(100 %)
4 diff
(99.5 %id)
BQ335694 marrow .a 2727 to 3310 601 to 18       584/601
(97 %)
0 diff
(100 %id)
BF813076 colon_ins .a 2756 to 3036 319 to 40     Submitted on the opposite strand 280/319
(87 %)
0 diff
(100 %id)
BE550486 pooled germ cell tumors .a 2764 to 3189 426 to 1       426/426
(100 %)
0 diff
(100 %id)
CN303253 embryonic stem cells, DMSO-treated H9 cellline .a 2778 to 3509 1 to 732       732/732
(100 %)
1 diff
(99.9 %id)
BI029498 marrow .a 2781 to 3286 515 to 9       507/519
(97 %)
0 diff
(100 %id)
AI206917 pooled germ cell tumors .a 2814 to 3186 373 to 1       373/373
(100 %)
0 diff
(100 %id)
CN303274 embryonic stem cells, DMSO-treated H9 cellline .a 2863 to 3572 1 to 710       710/710
(100 %)
1 diff
(99.9 %id)
DB369952   .a 2866 to 3442 575 to 1       575/575
(100 %)
4 diff
(99.4 %id)
CN303175 embryonic stem cells, DMSO-treated H9 cellline .a 2872 to 3440 1 to 569       569/569
(100 %)
0 diff
(100 %id)
BM695512 eye, optic nerve .a 2872 to 3475 1 to 604   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 604/604
(100 %)
1 diff
(99.9 %id)
CN303078 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2876 to 3299 1 to 424       424/424
(100 %)
0 diff
(100 %id)
BI029515 marrow .a 2884 to 3310 431 to 4       428/431
(99 %)
0 diff
(100 %id)
DB370021   .a 2902 to 3442 564 to 26   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 539/539
(100 %)
2 diff
(99.7 %id)
CN303169 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2908 to 3536 1 to 629       629/629
(100 %)
0 diff
(100 %id)
DB369597   .a 2923 to 3469 547 to 1       547/547
(100 %)
1 diff
(99.9 %id)
CX788657 human embryonic stem cells .a 2934 to 3709 1 to 776       776/776
(100 %)
1 diff
(99.9 %id)
BX335131 Placenta Cot 25-normalized .a 2945 to 3859 954 to 44       911/985
(92 %)
0 diff
(100 %id)
DA727751   .a 2959 to 3720 2 to 767   capped   766/774
(98 %)
15 diff
(98.1 %id)
DA727962   .a 2970 to 3721 2 to 754   capped   753/753
(100 %)
4 diff
(99.5 %id)
AW984049 head_normal .a 2974 to 3640 665 to 2     Submitted on the opposite strand 664/665
(99 %)
0 diff
(100 %id)
CN303138 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2981 to 3712 1 to 732       732/732
(100 %)
0 diff
(100 %id)
CN303174 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2984 to 3674 1 to 691       691/691
(100 %)
0 diff
(100 %id)
CN303212 embryonic stem cells, DMSO-treated H9 cellline .a 3058 to 3734 1 to 677   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 677/677
(100 %)
0 diff
(100 %id)
TI_154098027   .a 3076 to 3943 963 to 97   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 867/1182
(73 %)
17 diff
(98.6 %id)
DB363471   .a 3145 to 3734 592 to 1       592/592
(100 %)
13 diff
(97.9 %id)
DB370397   .a 3169 to 3734 569 to 1       569/576
(98 %)
5 diff
(99.2 %id)
DB369861   .a 3174 to 3734 557 to 1       557/557
(100 %)
10 diff
(98.3 %id)
CN303183 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3175 to 3734 1 to 560   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 560/560
(100 %)
0 diff
(100 %id)
DB369603   .a 3182 to 3734 550 to 1       550/550
(100 %)
10 diff
(98.2 %id)
DB370568   .a 3186 to 3734 546 to 1       546/547
(99 %)
10 diff
(98.2 %id)
DB370155   .a 3189 to 3734 547 to 1       547/547
(100 %)
9 diff
(98.4 %id)
CD368636 Alveolar Macrophage, lung .a 3192 to 3943 771 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 753/753
(100 %)
4 diff
(99.5 %id)
BU630451 cell lines, Chondrosarcoma .a 3198 to 3945 766 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 748/751
(99 %)
3 diff
(99.7 %id)
DB369744   .a 3206 to 3734 528 to 1       528/529
(99 %)
1 diff
(99.9 %id)
TI_154011188   .a 3207 to 3943 849 to 109   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 741/988
(75 %)
7 diff
(99.3 %id)
BF926543 nervous_tumor .a 3228 to 3665 437 to 1     Submitted on the opposite strand 437/437
(100 %)
5 diff
(98.9 %id)
DB369604   .a 3245 to 3734 491 to 1       491/522
(94 %)
2 diff
(99.7 %id)
TI_154136549   .a 3256 to 3938 748 to 58   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 691/1113
(62 %)
31 diff
(97.3 %id)
DB370335   .a 3269 to 3734 466 to 1       466/469
(99 %)
1 diff
(99.8 %id)
CX753980 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 3271 to 3944 683 to 9     Submitted on the opposite strand 675/683
(98 %)
0 diff
(100 %id)
AA515326 liposarcoma .a 3289 to 3742 447 to 1       447/447
(100 %)
16 diff
(96.5 %id)
CA440927 Chondrosarcoma, Left Pubic Bone .a 3308 to 3943 654 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 636/636
(100 %)
0 diff
(100 %id)
CN303154 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 3334 to 3704 1 to 371       371/371
(100 %)
0 diff
(100 %id)
TI_154133875   .a 3359 to 3943 677 to 89   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 589/1304
(45 %)
33 diff
(97.5 %id)
DB369802   .a 3376 to 3943 566 to 1       566/572
(98 %)
6 diff
(99.0 %id)
DB369807   .a 3377 to 3943 567 to 1       567/571
(99 %)
4 diff
(99.3 %id)
DB370384   .a 3379 to 3945 567 to 1       567/567
(100 %)
10 diff
(98.3 %id)
EL949196 eyeball .a 3390 to 3916 15 to 542       528/542
(97 %)
6 diff
(98.9 %id)
DB369766   .a 3398 to 3943 545 to 1       545/584
(93 %)
5 diff
(99.2 %id)
BP391417 pancreatic islet .a 3399 to 3938 1 to 540     Submitted on the opposite strand 540/540
(100 %)
4 diff
(99.3 %id)
DB370128   .a 3430 to 3945 515 to 1       515/556
(92 %)
6 diff
(99.0 %id)
DB370088   .a 3439 to 3943 503 to 1       503/508
(99 %)
8 diff
(98.5 %id)
DB550568 hippocampus .a 3445 to 3943 1 to 500     Submitted on the opposite strand 500/500
(100 %)
2 diff
(99.6 %id)
BU728925 eye, optic nerve .a 3445 to 3945 522 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 504/504
(100 %)
3 diff
(99.5 %id)
CN303182 embryonic stem cells, DMSO-treated H9 cellline .a 3447 to 3914 1 to 468       468/468
(100 %)
0 diff
(100 %id)
BP384379 pancreatic islet .a 3449 to 3946 1 to 498   tiling clone, Submitted on the opposite strand 498/501
(99 %)
2 diff
(99.7 %id)
AA102642 brain, neuroepithelial cells .a 3458 to 3944 486 to 1       486/486
(100 %)
7 diff
(98.6 %id)
DB571212 hypothalamus .a 3468 to 3943 1 to 476     Submitted on the opposite strand 476/476
(100 %)
4 diff
(99.2 %id)
DB572537 hypothalamus .a 3475 to 3943 1 to 469     Submitted on the opposite strand 469/469
(100 %)
4 diff
(99.2 %id)
DB569511 hypothalamus .a 3477 to 3943 1 to 467     Submitted on the opposite strand 467/467
(100 %)
4 diff
(99.2 %id)
DB541015 hippocampus .a 3479 to 3943 1 to 465     Submitted on the opposite strand 465/465
(100 %)
1 diff
(99.8 %id)
DB536076 hippocampus .a 3483 to 3943 1 to 465     Submitted on the opposite strand 465/465
(100 %)
9 diff
(98.1 %id)
DB540828 hippocampus .a 3487 to 3943 1 to 460     Submitted on the opposite strand 460/460
(100 %)
3 diff
(99.4 %id)
DB574489 hypothalamus .a 3502 to 3943 1 to 442     Submitted on the opposite strand 442/442
(100 %)
4 diff
(99.1 %id)
DB370281   .a 3502 to 3942 445 to 2       444/445
(99 %)
0 diff
(100 %id)
DB370484   .a 3502 to 3943 442 to 1       442/442
(100 %)
6 diff
(98.7 %id)
DB534584 hippocampus .a 3511 to 3943 1 to 434     Submitted on the opposite strand 434/434
(100 %)
9 diff
(98.0 %id)
DB370788   .a 3516 to 3943 428 to 1       428/428
(100 %)
4 diff
(99.1 %id)
DB530914 hippocampus .a 3518 to 3943 8 to 434     Submitted on the opposite strand 427/434
(98 %)
6 diff
(98.7 %id)
AA218724 brain, neuroepithelial cells .a 3524 to 3939 416 to 1       416/416
(100 %)
3 diff
(99.3 %id)
AW576151 lymph .a 3561 to 3943 401 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 384/384
(100 %)
6 diff
(98.5 %id)
CN303206 embryonic stem cells, cell lines H1, H7, andH9 .a 3572 to 3938 433 to 67   AAA Submitted on the opposite strand 367/372
(98 %)
17 diff
(95.5 %id)
CN303204 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 3587 to 3945 416 to 57   tiling clone, AAA Submitted on the opposite strand 360/360
(100 %)
1 diff
(99.8 %id)
DB369877   .a 3634 to 3943 314 to 1       314/314
(100 %)
3 diff
(99.1 %id)
DB324427   .a 3646 to 3943 301 to 3       299/310
(96 %)
0 diff
(100 %id)
DB370923   .a 3675 to 3943 272 to 3       270/272
(99 %)
0 diff
(100 %id)
BE302026 cervix .a 3682 to 3942 262 to 2       261/262
(99 %)
0 diff
(100 %id)
DB370474   .a 3682 to 3943 265 to 1       265/267
(99 %)
2 diff
(99.3 %id)
CX783249 human embryonic stem cells .a 3769 to 3943 216 to 42   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 175/175
(100 %)
12 diff
(93.2 %id)
DA645825 mammary gland .b 1 to 579 2 to 580   tiling clone, capped   579/579
(100 %)
2 diff
(99.7 %id)
BM548719 duodenal adenocarcinoma, cell line, small intestine .b 16 to 1007 1 to 1006 G123X V168G A169G E175G F176I ...     1006/1050
(95 %)
42 diff
(96.0 %id)
CR621471 Placenta Cot 25-normalized .b 18 to 1801 1 to 1784 exact tiling clone,   1784/1784
(100 %)
0 diff
(100 %id)
BX357715 Placenta Cot 25-normalized .b 18 to 994 1 to 967 exact fully sequenced,   967/967
(100 %)
2 diff
(99.8 %id)
BX357714 Placenta Cot 25-normalized .b 964 to 1777 833 to 24   fully sequenced,   810/833
(97 %)
11 diff
(98.7 %id)
DB360439 mammary gland .b 1277 to 1830 552 to 1   tiling clone,   552/553
(99 %)
11 diff
(98.1 %id)
CN334462 embryonic stem cells, DMSO-treated H9 cellline .b 1423 to 1830 1 to 408   AAA Possibly primed on the genome, locally A rich (19/21 A in genome downstream of last aligned base) 408/408
(100 %)
4 diff
(99.1 %id)
AA513892 liposarcoma .b 1424 to 1775 1 to 351       351/351
(100 %)
6 diff
(98.3 %id)
DW423641 Liver .b 1493 to 1767 17 to 291       275/291
(94 %)
6 diff
(98.0 %id)
DW439122 Liver .b 1493 to 1718 17 to 243       227/243
(93 %)
8 diff
(96.8 %id)
AI365362 pooled germ cell tumors .b 1499 to 1830 332 to 1       332/332
(100 %)
3 diff
(99.1 %id)
DA737039   .c 1 to 797 2 to 795   capped   794/794
(100 %)
5 diff
(99.4 %id)
DA737432   .c 1 to 729 2 to 730   capped   729/729
(100 %)
8 diff
(99.0 %id)
DA737463   .c 1 to 812 2 to 815   tiling clone, capped   814/828
(98 %)
9 diff
(99.0 %id)
DA737769   .c 1 to 766 2 to 766   capped   765/765
(100 %)
3 diff
(99.7 %id)
DA737962   .c 1 to 797 2 to 797   capped   796/796
(100 %)
6 diff
(99.3 %id)
DA738035   .c 1 to 766 2 to 767   capped   766/766
(100 %)
8 diff
(99.0 %id)
DA738241   .c 1 to 748 2 to 748   capped   747/751
(99 %)
4 diff
(99.5 %id)
DA738336   .c 2 to 797 2 to 793   capped Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 792/801
(98 %)
11 diff
(98.7 %id)
DA737069   .c 3 to 798 2 to 795   capped   794/797
(99 %)
9 diff
(98.9 %id)
DA737305   .c 3 to 731 2 to 730   capped   729/729
(100 %)
4 diff
(99.5 %id)
AB209607 Spleen .c 20 to 4433 1 to 4415 exact tiling clone,   4415/4415
(100 %)
4 diff
(100.0 %id)
DC304726 cerebellum .c 285 to 850 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
DA373353 thalamus .c 1089 to 1644 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BQ719120 sympathetic trunk .c 1263 to 2032 52 to 823   tiling clone,   772/921
(83 %)
9 diff
(99.1 %id)
DB370033   .c 3605 to 4224 613 to 1       613/615
(99 %)
9 diff
(98.6 %id)
DB369889   .c 3642 to 4224 583 to 1       583/584
(99 %)
9 diff
(98.5 %id)
DB370579   .c 3670 to 4224 554 to 1       554/556
(99 %)
10 diff
(98.3 %id)
DB370839   .c 3708 to 4224 519 to 1       519/563
(92 %)
4 diff
(99.3 %id)
DB370645   .c 3757 to 4224 466 to 1       466/468
(99 %)
7 diff
(98.6 %id)
DB370069   .c 3816 to 4435 613 to 1       613/617
(99 %)
10 diff
(98.4 %id)
DB370389   .c 3869 to 4428 559 to 1   tiling clone,   559/568
(98 %)
4 diff
(99.3 %id)
DB369600   .c 3882 to 4433 550 to 1       550/551
(99 %)
7 diff
(98.8 %id)
DB369629   .c 3882 to 4433 551 to 1       551/555
(99 %)
8 diff
(98.6 %id)
DB370926   .c 3944 to 4435 504 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 491/500
(98 %)
11 diff
(97.8 %id)
DB534399 hippocampus .c 4130 to 4421 1 to 318     Submitted on the opposite strand 318/318
(100 %)
56 diff
(82.4 %id)
BP391344 pancreatic islet .c 4138 to 4429 1 to 292     Submitted on the opposite strand 292/293
(99 %)
7 diff
(97.7 %id)
AA730542 Ewing's sarcoma .c 4216 to 4431 231 to 15   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 217/219
(99 %)
0 diff
(100 %id)
AA715227 alveolar rhabdomyosarcoma .c 4259 to 4409 154 to 1       154/154
(100 %)
3 diff
(98.1 %id)
AA665170 alveolar rhabdomyosarcoma .c 4259 to 4383 125 to 1       125/133
(93 %)
1 diff
(99.3 %id)
CD639865 pooled .c 4261 to 4428 1 to 168   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 168/168
(100 %)
2 diff
(98.9 %id)
GD153402   .c 4289 to 4436 1 to 148   tiling clone,   148/155
(95 %)
3 diff
(98.1 %id)
GD153410   .c 4289 to 4436 1 to 148       148/162
(91 %)
5 diff
(97.0 %id)
GD156813   .c 4289 to 4429 1 to 141       141/156
(90 %)
7 diff
(95.6 %id)
GD160166   .c 4289 to 4434 1 to 146       146/160
(91 %)
1 diff
(99.4 %id)
EH338582   .c 4328 to 4426 1 to 99       99/99
(100 %)
0 diff
(100 %id)
BY999025   .c 4332 to 4435 155 to 258     Submitted on the opposite strand 237/262
(90 %)
13 diff
(95.1 %id)
DB165369 thymus .d 1 to 576 2 to 577 exact tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
CN303112 embryonic stem cells, DMSO-treated H9 cellline .e 1 to 614 1 to 614   tiling clone,   614/616
(99 %)
6 diff
(99.1 %id)
BQ718375 sympathetic trunk .e 171 to 1035 1 to 878 exact tiling clone,   878/885
(99 %)
19 diff
(97.9 %id)
DA096596 cerebellum .f 1 to 553 2 to 554 exact capped   553/553
(100 %)
1 diff
(99.9 %id)
DA674688   .f 1 to 574 2 to 575 exact tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
DB194863 trachea .f 1 to 514 2 to 515 exact capped   514/514
(100 %)
2 diff
(99.7 %id)
DB237183 trachea .f 1 to 589 2 to 590 exact tiling clone, capped   589/590
(99 %)
2 diff
(99.7 %id)
DB280184 uterus .f 1 to 546 2 to 548 exact capped   547/547
(100 %)
3 diff
(99.5 %id)
CB987723 Pooled-Glandular .g 1 to 707 5 to 718 L59V F88L tiling clone,   718/843
(85 %)
23 diff
(97.3 %id)
DB111770 thymus .g 2 to 550 2 to 550 exact capped   549/549
(100 %)
1 diff
(99.9 %id)
DA672242   .g 3 to 569 2 to 568 exact tiling clone, capped   567/567
(100 %)
1 diff
(99.9 %id)
BQ331533 lung_tumor .g 298 to 677 376 to 1   tiling clone,   376/379
(99 %)
9 diff
(97.7 %id)
R85888 eye, retina .g 355 to 811 479 to 5   tiling clone,   475/483
(98 %)
0 diff
(100 %id)
BQ333044 lung_tumor .g 534 to 863 336 to 7   tiling clone,   330/336
(98 %)
0 diff
(100 %id)
BQ709630 Spleen .h 1 to 943 1 to 954 exact tiling clone,   954/956
(99 %)
29 diff
(97.0 %id)
BQ717091 sympathetic trunk .h 594 to 1298 1 to 709   tiling clone,   709/928
(76 %)
17 diff
(98.2 %id)
AL709526 human skeletal muscle .h 762 to 1125 1 to 364       364/364
(100 %)
5 diff
(98.7 %id)
BM008034 Spleen .h 857 to 1508 1 to 656       656/656
(100 %)
6 diff
(99.1 %id)
TI_59383445   .h 857 to 1508 66 to 721       656/656
(100 %)
6 diff
(99.1 %id)
BQ708759 Spleen .h 860 to 1684 1 to 832   tiling clone,   832/855
(97 %)
15 diff
(98.3 %id)
DA193257.
matches multiple genes
amygdala .h 1117 to 1718 2 to 603   tiling clone, capped also hits gene tenore 602/602
(100 %)
2 diff
(99.7 %id)
DB139446 thymus .i 1 to 540 2 to 540 exact capped   539/539
(100 %)
2 diff
(99.7 %id)
DB165451 thymus .i 1 to 588 2 to 589 exact tiling clone, capped   588/588
(100 %)
1 diff
(99.9 %id)
AW873022 adrenal gland, neuroblastoma .i 539 to 1132 595 to 1   tiling clone,   595/595
(100 %)
6 diff
(99.0 %id)
DW410389 Liver .i 1101 to 1428 10 to 334   tiling clone,   325/334
(97 %)
7 diff
(98.0 %id)
CB989584 Human Placenta, placenta .j-u 1 to 774 29 to 809   tiling clone,   789/918
(85 %)
17 diff
(98.2 %id)
CD685131 normal nasopharynx .j-u 1 to 565 34 to 598       569/598
(95 %)
6 diff
(99.0 %id)
DW410805 Liver .j-u 1 to 314 19 to 332       315/332
(94 %)
6 diff
(98.2 %id)
DW411226 Liver .j-u 1 to 312 19 to 330       313/330
(94 %)
6 diff
(98.2 %id)
DW429570 Liver .j-u 1 to 382 19 to 400       383/400
(95 %)
10 diff
(97.5 %id)
DW445976 Liver .j-u 1 to 201 19 to 219       202/219
(92 %)
6 diff
(97.3 %id)
DW418188 Liver .j-u 1 to 286 17 to 304       288/304
(94 %)
6 diff
(98.1 %id)
DA824504 pericardium .j-u 1 to 557 2 to 558   capped   557/557
(100 %)
1 diff
(99.9 %id)
DA869901 Prostate .j-u 1 to 555 2 to 556   capped   555/557
(99 %)
2 diff
(99.7 %id)
DA898618 skeletal muscle .j-u 1 to 559 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
DA926364 small intestine .j-u 1 to 580 2 to 581   capped   580/580
(100 %)
1 diff
(99.9 %id)
DB236073 trachea .j-u 1 to 585 2 to 586   capped   585/585
(100 %)
2 diff
(99.7 %id)
DB282794 uterus .j-u 1 to 548 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB287346 uterus .j-u 2 to 559 2 to 559   capped   558/558
(100 %)
2 diff
(99.7 %id)
DB290664 uterus .j-u 3 to 585 2 to 584   capped   583/583
(100 %)
2 diff
(99.7 %id)
DB215699 trachea .j-u 4 to 324 2 to 322   capped   321/321
(100 %)
1 diff
(99.7 %id)
DB240439 trachea .j-u 4 to 593 2 to 591   tiling clone, capped   590/590
(100 %)
1 diff
(99.9 %id)
CN412064 embryonic stem cells, cell lines H1, H7, andH9 .j-u 19 to 689 1 to 671       671/671
(100 %)
2 diff
(99.8 %id)
DW419167 Liver .j-u 140 to 545 1 to 407       407/407
(100 %)
11 diff
(97.3 %id)
DW446367 Liver .j-u 140 to 356 1 to 217       217/217
(100 %)
8 diff
(96.4 %id)
DW432463 Liver .j-u 296 to 544 17 to 265       249/265
(93 %)
6 diff
(97.8 %id)
BF871039 lung_tumor .j-u 306 to 709 402 to 1     Submitted on the opposite strand 402/403
(99 %)
2 diff
(99.6 %id)
DW415151 Liver .j-u 506 to 803 16 to 313   tiling clone,   298/313
(95 %)
7 diff
(97.8 %id)
DW423078 Liver .j-u 506 to 782 16 to 292   tiling clone,   277/292
(94 %)
6 diff
(98.0 %id)
DW432391 Liver .j-u 506 to 752 16 to 265       250/265
(94 %)
6 diff
(97.8 %id)
DW462693 Liver .j-u 506 to 856 16 to 366       351/366
(95 %)
6 diff
(98.4 %id)
DW439335 Liver .j-u 602 to 834 10 to 242       233/242
(96 %)
6 diff
(97.6 %id)
DW456472 Liver .j-u 602 to 760 10 to 168       159/168
(94 %)
6 diff
(96.5 %id)
BF911534 uterus_tumor .j-u 779 to 1059 287 to 7   tiling clone, Submitted on the opposite strand 281/290
(96 %)
0 diff
(100 %id)
BX502858 Liver .j-u 1034 to 1756 1 to 723   tiling clone,   723/723
(100 %)
3 diff
(99.6 %id)
BQ940263 sciatic nerve .j-u 1238 to 2096 1 to 876 E31G S32V G33W V34G Q35Y ... tiling clone,   876/923
(94 %)
28 diff
(97.0 %id)
R84782.
matches multiple genes
eye, retina .j-u 1462 to 1774 1 to 319     also hits gene SKIL 319/319
(100 %)
7 diff
(97.9 %id)
CD652963 Embryonic Stem cells .j-u 1496 to 2263 1 to 766 Q26H tiling clone,   766/848
(90 %)
6 diff
(99.3 %id)
BI037814 nervous_tumor .j-u 1498 to 1947 456 to 9       448/456
(98 %)
0 diff
(100 %id)
AL138113 brain .j-u 1502 to 2092 1 to 592 Q26H     592/592
(100 %)
2 diff
(99.7 %id)
CV428264 head_neck .j-u 1561 to 1856 3 to 295       293/295
(99 %)
6 diff
(98.0 %id)
BF902790 marrow .j-u 1588 to 1995 1 to 409 A28S I36D R37Q L38T H39A ...     409/420
(97 %)
5 diff
(98.9 %id)
BI028590 marrow .j-u 1588 to 1918 1 to 331       331/331
(100 %)
2 diff
(99.4 %id)
AW946873 lung_tumor .j-u 1863 to 2088 16 to 239       224/239
(93 %)
6 diff
(97.5 %id)
DA939364 Spleen .k 1 to 589 2 to 590 exact tiling clone, capped   589/589
(100 %)
1 diff
(99.9 %id)
BU660539 blood .k 525 to 1009 8 to 492   tiling clone,   485/492
(98 %)
6 diff
(98.8 %id)
CN482959 eye .k 775 to 1362 1 to 588   tiling clone,   588/588
(100 %)
1 diff
(99.9 %id)
AL603344 human skeletal muscle .l-u 1 to 410 1 to 416   tiling clone,   416/420
(99 %)
9 diff
(97.9 %id)
BF849010 lung_normal .l-u 309 to 696 28 to 414 exact tiling clone,   387/426
(90 %)
3 diff
(99.3 %id)
BF854912 prostate_normal .l-u 509 to 778 43 to 310   tiling clone,   268/310
(86 %)
6 diff
(98.1 %id)
DA890052 rectum .l-u 518 to 1081 2 to 566   tiling clone, capped   565/565
(100 %)
1 diff
(99.9 %id)
BE828286 lung_tumor .m-u 1 to 571 572 to 2   tiling clone,   571/615
(92 %)
0 diff
(100 %id)
AA648109 Ewing's sarcoma .m-u 411 to 846 1 to 434 G59C T63L L64S N65T Q66S ... tiling clone,   434/434
(100 %)
7 diff
(98.4 %id)
CN303134.
matches multiple genes
embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 1 to 232 6 to 237     also hits gene SLC2A14 232/237
(97 %)
5 diff
(97.9 %id)
CN303192 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .n 2 to 532 1 to 531   tiling clone,   531/531
(100 %)
0 diff
(100 %id)
AA094376   .n 33 to 252 1 to 218       218/229
(95 %)
6 diff
(97.4 %id)
BF848024 lung_normal .n 53 to 357 306 to 1     Submitted on the opposite strand 306/315
(97 %)
8 diff
(97.5 %id)
AI968696.
matches multiple genes
pooled germ cell tumors .n 106 to 216 137 to 27   AAA also hits gene SLC2A14 111/111
(100 %)
1 diff
(99.1 %id)
T29744 skin .n 147 to 454 1 to 308       308/308
(100 %)
0 diff
(100 %id)
AW882332.
matches multiple genes
ovary .n 148 to 284 1 to 137     also hits gene SLC2A14 137/145
(94 %)
5 diff
(96.6 %id)
BF760717 colon .n 153 to 390 236 to 1     Submitted on the opposite strand 236/238
(99 %)
8 diff
(96.7 %id)
EH341998   .n 271 to 338 1 to 67       67/67
(100 %)
1 diff
(98.6 %id)
BF846352 lung_normal .n 303 to 487 366 to 182     Submitted on the opposite strand 185/366
(50 %)
0 diff
(100 %id)
AI825200 pooled germ cell tumors .n 451 to 833 385 to 1 V7C I8N A10S L11T W12L ... tiling clone,   385/385
(100 %)
3 diff
(99.3 %id)
DW465420 Liver .o-u 1 to 342 17 to 358 exact tiling clone,   342/358
(95 %)
6 diff
(98.4 %id)
CN269379 embryonic stem cells, DMSO-treated H9 cellline .o-u 104 to 734 1 to 632   tiling clone,   632/632
(100 %)
1 diff
(99.9 %id)
AA382171   .o-u 432 to 758 327 to 1   tiling clone,   327/327
(100 %)
3 diff
(99.1 %id)
TI_151750622   Gene SLC2A3, variant not shown       AAA Suspected internal deletion, this clone was ignored    
DB539905 hippocampus Gene SLC2A3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
AK304509 uterus Gene SLC2A3, variant not shown         This clone was ignored    
DC419909 uterus Gene SLC2A3, variant not shown         This clone was ignored    
DC428798   Gene SLC2A3, variant not shown         Suspected internal deletion, this clone was ignored    
AK298673   Gene SLC2A3, variant not shown         Suspected internal deletion, this clone was ignored    
BF342576 brain, glioblastoma with EGFR amplification Gene SLC2A3, variant not shown         This clone was ignored    
DC408102 thymus Gene SLC2A3, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
TI_159681647   Gene SLC2A3, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
DC418607 trachea Gene SLC2A3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j-u, .k, .l-u, .m-u, .n, .o-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI